The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Bromodomain protein 4 (Brd4) plays critical roles in development, cancer progression, and virus-host pathogenesis. To gain mechanistic insight into the various biological functions of Brd4, we performed a proteomic analysis to identify and characterize Brd4-associated cellular proteins. We found that the extraterminal (ET) domain, whose function has to date not been determined, interacts with NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5. These ET-domain interactions were also conserved for Brd2 and Brd3, the other human BET proteins tested. We demonstrated that GLTSCR1, NSD3, and JMJD6 impart a pTEFb-independent transcriptional activation function on Brd4. NSD3 as well as JMJD6 is recruited to regulated genes in a Brd4-dependent manner. Moreover, we found that depletion of Brd4 or NSD3 reduces H3K36 methylation, demonstrating that the Brd4/NSD3 complex regulates this specific histone modification. Our results indicate that the Brd4 ET domain through the recruitment of the specific effectors regulates transcriptional activity. In particular, we show that one of these effectors, NSD3, regulates transcription by modifying the chromatin microenvironment at Brd4 target genes. Our study thus identifies the ET domain as a second important transcriptional regulatory domain for Brd4 in addition to the carboxyl-terminal domain (CTD) that interacts with pTEFb.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N-terminal bromodomains confer binding to acetylated histone H3 and H4 tails, while the C-terminal extraterminal domain interacts with chromatin modifying enzymes such as histone methyltransferase NSD3 (REF.119,120).”
From Structure and function of retroviral integrase (2022) · cites this paper as [120]
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“H3K36me3 levels were higher within the coding region, peaking at the 3 end, than at the promoter in accordance with published findings (2).”
ResultDefining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Self-citationCarrozza, M. J., Li, B., Florens, L., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W.-J., Anderson, S., Yates, J., Washburn, M. P., et al. (2005) · Cell · doi:10.1016/j.cell.2005.10.023 · Cited by 1,294 · cited 1×
“Studies ranging from yeast to humans suggest that methylated H3K36 is enriched in regions of active transcription and is linked to transcriptional elongation and productive transcription within coding regions (5, 48, 49, 53).”
BackgroundJang, M. K., Mochizuki, K., Zhou, M., Jeong, H.-S., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,291 · cited 3×
“Many different BET family members, including the yeast bdf1/bdf2, Drosophila fs(1)h, and the mammalian Brd2, Brd3, and Brd4 proteins, have been implicated in transcription regulation (11, 13, 24, 27, 32).”
BackgroundRecruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138 · cited 2×
“However, only the CTD, present solely in Brd4 and fs(1)h, has been rigorously documented to regulate transcription through its interaction with pTEFb (4, 24, 56).”
BackgroundXue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985 · cited 1×
“CHD4 was observed to interact with components of the NuRD corepressor complex also as predicted previously (54).”
BackgroundJMJD6 Is a Histone Arginine Demethylase
Chang, B., Chen, Y., Zhao, Y., & Bruick, R. K. (2007) · Science · doi:10.1126/science.1145801 · Cited by 745 · cited 1×
“It was initially reported to be a histone arginine demethylase, responsible for H3R2me and H4R3me modifications (6).”
BackgroundControl of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation
Hargreaves, D. C., Horng, T., & Medzhitov, R. (2009) · Cell · doi:10.1016/j.cell.2009.05.047 · Cited by 644 · cited 2×
“A recent study demonstrates that transcription of primary responsive genes in stimulated macrophages is dependent on Brd4 and is linked to production of mature spliced transcripts (19).”
BackgroundBRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French, C. A., Miyoshi, I., Kubonishi, I., Grier, H. E., Pérez‐Atayde, A. R., & Fletcher, J. A. (2003) · PubMed · Cited by 501
The human Mi-2/NuRD complex and gene regulation
Denslow, S. A., & Wade, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210611 · Cited by 478 · cited 1×
“Notably, evidence suggests that it is involved in repression of genes that are regulated by estrogen receptor (12).”
Background
Research works printed but not linked: 2
- Denis G. V., 2000, Cell Growth Differ, 11, 417
- French C. A., 2003, Cancer Res, 63, 304
Cited by
Items 301–400 of 554
CxxC-ZF Domain Is Needed for KDM2A to Demethylate Histone in rDNA Promoter in Response to Starvation
Tanaka, Y., Umata, T., Okamoto, K., Obuse, C., & Tsuneoka, M. (2014) · Cell Structure and Function · doi:10.1247/csf.13022 · Cited by 26
“Another complexity is brought by the fact that the methyltransferases often create not only H3K36me2 but also H3K36me3 in cells (Nimura et al., 2009; Rahman et al., 2011).”
BackgroundBdf1 Bromodomains Are Essential for Meiosis and the Expression of Meiotic-Specific Genes
García-Oliver, E., Ramus, C., Perot, J., Arlotto, M., Champleboux, M., Mietton, F., Battail, C., Boland, A., Deleuze, J., Ferro, M., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006541 · Cited by 25
Biamonti, G., Maita, L., & Montecucco, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00408 · Cited by 25
“It has been suggested that the recruitment of JMJD6 to gene body in a BRD4-dependent manner (147) could be important for proper RNA splicing.”
BackgroundTakemon, Y., Leblanc, V., Song, J., Chan, S. Y., Lee, S. D., Trinh, D. L. N., Ahmad, S. T., Brothers, W. R., Corbett, R., Gagliardi, A., et al. (2023) · Cancers · doi:10.3390/cancers15102805 · Cited by 22
“Our co-essentiality and co-expression analyses indicated that CIC may share functionality with BICRA/GLTSCR1, a component of the recently identified non-canonical GBAF SWI/SNF complex [67].”
BackgroundErythropoiesis provides a BRD's eye view of BET protein function
Stonestrom, A. J., Hsu, S. C., Werner, M. T., & Blobel, G. A. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.05.004 · Cited by 22
“The ET domain is ~80% conserved between BET family members, and BRD2 and BRD3 also bind to many of the same complexes [25,26].”
BackgroundGLTSCR1 Negatively Regulates BRD4‐Dependent Transcription Elongation and Inhibits CRC Metastasis
Han, F., Zhang, L., Chen, C., Wang, Y., Zhang, Y., Qian, L.-L., Sun, W., Zhou, D., Yang, B., Zhang, H.-H., et al. (2019) · Advancement of science · doi:10.1002/advs.201901114 · Cited by 23
Zhang, Y., Fong, K.-W., Mao, F., Wang, R., Allison, D. B., Napier, D. L., He, D., Liu, J., Zhang, Y., Chen, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114431 · Cited by 25
RNA Polymerase II CTD Modifications: How Many Tales From a Single Tail
Napolitano, G., Lania, L., & Majello, B. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24483 · Cited by 29
“Nevertheless, Ser2-CTD residue has been also demonstrated to be a target of BRD4 activity (Rahman et al., 2011; Devaiah et al., 2012).”
BackgroundMolecular structures guide the engineering of chromatin
Tekel, S. J., & Haynes, K. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx531 · Cited by 23
“Isolated BRD domains from Gcn5p, BRD2 and BRD4 interact with acetylated histone tail peptides in 3D structure studies and in affinity assays (79,80,82,83).”
BackgroundInfluentialCDK9‐mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery
Brauns‐Schubert, P., Schubert, F., Wissler, M., Weiß, M., Schlicher, L., Bessler, S., Safavi, M., Miething, C., Borner, C., Brummer, T., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744311 · Cited by 22
“pcDNA4-TO-HA-BRD4 had been described by others [32] and received from Addgene (Peter Howley).”
Functions of histone modifications and histone modifiers in Schwann cells
Duman, M., Martínez-Moreno, M., Jacob, C., & Tapinos, N. (2020) · Glia · doi:10.1002/glia.23795 · Cited by 21
“NSD3 is a H3K36 methyltransferase that catalyzes mono- and dimethylation of H3K36 and also promotes H3K36 trimethylation in gene bodies (Rahman et al., 2011).”
BackgroundThe emerging roles of histone demethylases in cancers
Tong, D., Tang, Y., & Zhong, P. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10160-9 · Cited by 20
BET Bromodomain Inhibition Suppresses Human T Cell Function
Georgiev, P., Wang, Y., Muise, E. S., Bandi, M. L., Blumenschein, W. M., Sathe, M., Pinheiro, E. M., & Shumway, S. D. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900037 · Cited by 22
“BRD4 also directs the assembly of chromatin complexes, where it plays a critical role in transcriptional initiation and elongation, the latter driven by its capacity to interact with P-TEFb (28, 29).”
BackgroundKosno, M., Currie, S. L., Kumar, A., Xing, C., & Rosen, M. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-39102-9 · Cited by 19
“4 through assembly of these factors, which collectively recruit and activate RNA polymerase II to produce mRNA [12, 13].”
BackgroundNoval advance of histone modification in inflammatory skin diseases and related treatment methods
Zhang, L., Chai, R., Tai, Z., Miao, F., Shi, X., Chen, Z., & Zhu, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286776 · Cited by 20
Caputo, V. S., Trasanidis, N., Xiao, X., Robinson, M. E., Katsarou, A., Ponnusamy, K., Prinjha, R. K., Smithers, N. N., Chaidos, A., Auner, H. W., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101989 · Cited by 19
Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses
McBride, A. A., Warburton, A., & Khurana, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.725794 · Cited by 19
“Brd4 also recruits NSD3, JMJD6, and GLTSCR1 through interactions with the ET domain and these contribute to transcriptional activation in a pTEFb independent manner (Rahman et al., 2011).”
BackgroundGenome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma
Parris, T. Z., Rönnerman, E. W., Engqvist, H., Biermann, J., Truvé, K., Nemes, S., Forssell-Aronsson, E. B., Solinas, G., Kovács, A., Karlsson, P., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25329 · Cited by 20
Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA
Walker, C. J., Oakes, C. C., Genutis, L. K., Giacopelli, B., Liyanarachchi, S., Nicolet, D., Eisfeld, A., Scholz, M. R., Brock, P. L., Kohlschmidt, J., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0281-z · Cited by 19
DeSmet, M. L., Jose, L., Isaq, N. A., & Androphy, E. J. (2019) · Journal of Virology · doi:10.1128/jvi.01801-18 · Cited by 19
“The extra terminal (ET) domain interacts with NSD3, JMJD6, and GLTSCR1 to impart the transcriptional activation function (45).”
BackgroundThe "Histone Mimicry" by Pathogens
Schaefer, U., Ho, J., Prinjha, R. K., & Tarakhovsky, A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020339 · Cited by 20
“BET proteins can also contribute to RNA synthesis by a bromodomain-independent association with Paf1C as well as with numerous effector proteins such as NSD3, a SET domain-containing histone methyltransferase; JMJD6, a histone arginine demethylase; or Chd4, a catalytic component of the NuRD nucleosome remodeling compl…”
BackgroundNSD3: Advances in cancer therapeutic potential and inhibitors research
Xiu, S., Chi, X., Jia, Z., Cheng, S., Zhang, X., Li, Q., Gao, T., Zhang, L., & Liu, Z. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115440 · Cited by 18
BRD4 as a Therapeutic Target in Pulmonary Diseases
Guo, X., Olajuyin, A. M., Tucker, T. A., Idell, S., & Qian, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713231 · Cited by 19
Yang, J. F., Liu, W., & You, J. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011598 · Cited by 18
Studying epigenetic complexes and their inhibitors with the proteomics toolbox
Weigt, D., Hopf, C., & Médard, G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0244-z · Cited by 19
“A co-purification of HAtagged N-terminal domain of Brd4 revealed that the extraterminal domain of Brd4 recruits different effectors including NSD3 and JMJD6, which mediates transcriptional activation independent of pTEFb [94].”
BackgroundBETting on a Transcriptional Deficit as the Main Cause for Cornelia de Lange Syndrome
García‐Gutiérrez, P., & García‐Domínguez, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.709232 · Cited by 20
“The asymmetry in the fraction of co-interactors, besides suggesting NIPBL-independent roles for BRD4, may also reflect the limited knowledge on NIPBL interactome compared to BRD4, a factor for which several proteomic screens have been published uncovering more than a thousand different candidates (Jang et al., 2005; R…”
BackgroundBET Proteins: An Approach to Future Therapies in Transplantation
Suárez-Álvarez, B., Rodríguez, R. M. A., Ruiz‐Ortega, M., & López‐Larrea, C. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14221 · Cited by 19
“After recruitment, the effect of BRD4 on the P-TEFb complex is twofold: first, BRD4 mediates the release of the 7SK snRNA/HEXIM1 inhibitory complex, which allows polymerase II pause release and the generation of the transcription-initiation complex (14); second, BRD4 exerts a kinase activity that phosphorylates the se…”
BackgroundSchütt, J., Nägler, T. M., Schenk, T., & Brioli, A. (2021) · Cancers · doi:10.3390/cancers13164069 · Cited by 19
“In particular, JQ1, a small inhibitor of acetyl-lysine recognition motifs, has been found to competitively bind to bromodomains [101].”
BackgroundZheng, X., Diktonaite, K., & Qiu, H. (2023) · Biomolecules · doi:10.3390/biom13071135 · Cited by 17
“The BRD4 ET domain could recruit proteins, including nuclear receptor binding SET domain protein 3 (NSD3), oxygenase JMJD6, and glioma tumor suppressor candidate region gene 1 (GLTSCR1), to form a complex that enables a positive transcription elongation factor (P-TEFb)-independent transcriptional activation [36,37].”
BackgroundTheofel, I., Bartkuhn, M., Hundertmark, T., Boettger, T., Gärtner, S. M. K., Leser, K., Awe, S., Schipper, M., Renkawitz‐Pohl, R., & Rathke, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108267 · Cited by 18
“recruiting specific factors to chromatin [23].”
Luna-Peláez, N., & García‐Domínguez, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.023 · Cited by 17
Xing, E., Surendranathan, N., Kong, X., Cyberski, N., Garcia, J. D., Cheng, X., Sharma, A., Li, P., & Larue, R. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00159 · Cited by 17
Viral Hijacking of BET Proteins
Chen, I. P., & Ott, M. (2022) · Viruses · doi:10.3390/v14102274 · Cited by 18
Role of bromodomain and extraterminal (BET) proteins in prostate cancer
Mandl, A., Markowski, M. C., Carducci, M. A., & Antonarakis, E. S. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2186851 · Cited by 18
Jones-Tabah, J., Martin, R. D., Chen, J. J., Tanny, J. C., Clarke, P. B. S., & Hébert, T. E. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110226 · Cited by 17
Bernau, K., Skibba, M. E., Leet, J. P., Furey, S., Gehl, C., Li, Y., Zhou, J., Sandbo, N. K., & Brasier, A. R. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.842558 · Cited by 16
“For example, BRD4 interacts with acetylated histones and transcription factors through its BDs, with transcriptional regulators through its extraterminal domain, and with transcriptional elongation kinases through its carboxyterminal domain (Bisgrove et al., 2007; Rahman et al., 2011; Mann et al., 2021).”
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
Kloker, L. D., Calukovic, B., Benzler, K., Golf, A., Böhm, S., Günther, S., Horger, M., Haas, S., Berchtold, S., Beil, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.995744 · Cited by 16
Kim, Y. H., Kim, M., Yoo, M., Kim, J. E., Lee, H. K., Heo, J., Lee, C. O., Yoo, M., Jung, K., Yun, C., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.091 · Cited by 16
Bet Bromodomains’ Functions in Bone-Related Pathologies
Jacques, C., Lavaud, M., Georges, S., Tesfaye, R. A., Baud’huin, M., Lamoureux, F., & Ory, B. (2019) · Epigenomics · doi:10.2217/epi-2019-0172 · Cited by 16
Molecularly Targeted Therapies in Oncology: Mechanisms, Resistance, and Combination Strategies
Giercuszkiewicz-Haśnik, K., MORAK-MŁODAWSKA, B. I., & Jeleń, M. (2026) · Molecules · doi:10.3390/molecules31071195 · Cited by 15
Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase
Rathert, P. (2021) · Life · doi:10.3390/life11080726 · Cited by 18
Relevance of BET Family Proteins in SARS-CoV-2 Infection
Lara-Ureña, N., & García‐Domínguez, M. (2021) · Biomolecules · doi:10.3390/biom11081126 · Cited by 15
“The ET domain consists of a region of approximately 80 amino acids and is involved in the interaction with specific effector proteins [58,59].”
BackgroundMa, X., Du, T., Zhu, D., Chen, X., Lai, Y., Wu, W., Wang, Q., Lin, C., Li, Z., Liu, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9490 · Cited by 15
“A previous study demonstrated that GLTSCR1 is able to upregulate Pim-2 oncogene (PIM2) in C33A cells (22).”
Non-canonical transcriptional consequences of BET inhibition in cancer
Letson, C. T., & Padron, E. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104508 · Cited by 15
PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance
Giardina, S. F., Valdambrini, E., Warren, J. D., & Barany, F. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210203110857 · Cited by 15
Laliotis, G., Chavdoula, E., Paraskevopoulou, M. D., Kaba, A., Ferlita, A. L., Singh, S. V., Anastas, V., Nair, K. A., Orlacchio, A., Taraslia, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24795-1 · Cited by 15
RetractedValín, Á., Ouyang, J., & Gill, G. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-12 · Cited by 14
Histone Modifications and Their Targeting in Lymphoid Malignancies
Fernández-Serrano, M., Winkler, R., Santos, J. C., Pannérer, M.-M. L., Buschbeck, M., & Roué, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010253 · Cited by 15
“demethylases, thus, depleting BRD4 reduced H3K36 methylation [110].”
NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
Nuñez, Y., Vera, S., Baeza, V., & González-Pecchi, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020944 · Cited by 13
“Sun et al. reported that in NSD3 knockout pancreatic cells and in shRNA-xenografts, there was a decrease in the gene expression of Myc , Adam12 , and Notch3 , demonstrating that the silencing of NSD3 can downregulate oncogenic genes [48].”
BackgroundHow does CHD4 slide nucleosomes?
Reid, X. J., Zhong, Y., & Mackay, J. P. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230070 · Cited by 13
Xu, X., Mann, M. W., Qiao, D., Li, Y., Zhou, J., & Brasier, A. R. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.728661 · Cited by 16
“BRD4 interacts with acetylated histones and transcription factors through its conserved bromodomain (BD), with transcriptional regulators through its extraterminal domain, and with transcriptional elongation kinases through its carboxyterminal domain (Bisgrove et al., 2007; Rahman et al., 2011; Zou et al., 2014; Mann…”
BackgroundDiscovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs
Piao, L., Gao, Y., Xu, X., Su, Y., Wang, Y. D., Zhou, J., Gao, Y., Fang, J., Li, Q., Chang, S., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116264 · Cited by 13
Suzuki, K., Yamamoto, K., Arakawa, Y., Yamada, H., Aiba, K., & Kitagawa, M. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000389 · Cited by 13
Fragment‐Based Drug Discovery in the Bromodomain and Extra‐Terminal Domain Family
Radwan, M., & Serya, R. A. T. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201700147 · Cited by 13
A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.
Shin, D., & Bayarsaihan, D. (2017) · PubMed Central · Cited by 14
Dynamic Changes of the Epigenetic Landscape During Cellular Differentiation
Dambacher, S., de Almeida, G. P., & Schotta, G. (2013) · Epigenomics · doi:10.2217/epi.13.67 · Cited by 16
Virus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding
Burgess, A. E., Kleffmann, T., & Mace, P. D. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167242 · Cited by 12
Herbison, H., Davis, S. R., Nickless, D. K., Haydon, A. M., & Ameratunga, M. (2023) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-23-19 · Cited by 12
Rosenthal, Z. C., Fass, D. M., Payne, N. C., She, A., Patnaik, D., Hennig, K. M., Tesla, R., Werthmann, G. C., Guhl, C., Reis, S. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59110-7 · Cited by 13
“Through the Extra-Terminal (ET) domain, BET family members can interact with various transcriptional regulators, including CHD4, ATAD5, and JMJD6 32 .”
BackgroundInternational guidelines on the diagnosis and treatment of NUT carcinoma
Zhang, Y., Zhang, Q., Yue, H., Luo, J., Piao, Y., Wang, W., Song, Z., Li, Z., Brčić, L., Liu, A., et al. (2025) · The Innovation · doi:10.1016/j.xinn.2025.101068 · Cited by 20
Bromodomain and extraterminal domain protein bromodomain inhibitor based cancer therapeutics
Ghosh, T., Soldi, R., & Sharma, S. (2021) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000763 · Cited by 12
“is a conserved region of nearly 80 amino acids that achieves its regulatory function by engaging specific effector proteins [17].”
BackgroundSanchez, J., Kaur, P. P., Pabuayon, I. C. M., Karampudi, N. B. R., Kitazumi, A., Sandhu, N., Catolos, M., Kumar, A., & Reyes, B. G. D. L. (2021) · The Plant Genome · doi:10.1002/tpg2.20168 · Cited by 12
“The DEC protein potentially functions as a transcriptional regulator based on the N-terminus glutamine-rich domain associated with chromatin remodeling functions (Ding et al., 2006; Freiman & Tjian, 2002; Rahman et al., 2011; Saluja et al., 1998; Wu & Chi-ang, 2007).”
ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair
Bachus, S., Akkerman, N., Fulham, L., Graves, D., Helwer, R., Rempel, J., & Pelka, P. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae208 · Cited by 12
“31358) and was previously described ( 23 ), it expresses a FLAG and HA-tagged JMJD6.”
BackgroundMondal, A., Singh, B., Felkner, R. H., Falco, A. D., Swapna, G., Montelione, G. T., Roth, M. J., & Pérez, A. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405767 · Cited by 12
Targeting Epigenetics to Prevent Obesity Promoted Cancers
Berger, N. A., & Scacheri, P. C. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0043 · Cited by 12
“Accordingly, major efforts have been focused on developing BET domain inhibitors with emphasis on their use as cancer therapeutics (21).”
BackgroundYang, Y., Chen, P., Zhao, L., Zhang, F., Zhang, B., Xu, C., Zhang, H., & Zhou, J. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103044 · Cited by 12
Protective effect of histone methyltransferase NSD3 on ISO‐induced cardiac hypertrophy
Chen, K., Jian, D., Zhao, L., Zang, X., Song, W., Ma, J., Jia, Z. H., Wang, X., & Gao, C. (2019) · FEBS Letters · doi:10.1002/1873-3468.13515 · Cited by 12
Jacques-Fricke, B. T., Roffers‐Agarwal, J., Hussein, A. O., Yoder, K. J., Gearhart, M. D., & Gammill, L. S. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2021.02.015 · Cited by 13
Groves, A. P., Clymer, J. R., & Filbin, M. G. (2022) · Pharmaceuticals · doi:10.3390/ph15060665 · Cited by 13
“The BET extra-terminal domain (ET) is able to recruit other chromatin-regulating proteins, such as NSD3, JMJDs, and CHD4 [32].”
BackgroundBET Proteins are a Key Component of Immunoglobulin Gene Expression
Shim, J. M., Lee, J. S., Russell, K. E., Wiegman, C., Barnes, P. J., Fear, D. J., Adcock, I. M., & Durham, A. L. (2017) · Epigenomics · doi:10.2217/epi-2016-0147 · Cited by 12
The Role of Histone Methylation and Methyltransferases in Gene Regulation
Cui, J. Y., Fu, Z. D., & Dempsey, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812433-8.00002-2 · Cited by 17
Reyes‐Gutierrez, P., Carrasquillo-Rodríguez, J. W., & Imbalzano, A. N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216015 · Cited by 12
Alahari, S., Farrell, A., Ermini, L., Park, C., Sallais, J., Roberts, S., Gillmore, T., Litvack, M. L., Post, M., & Caniggia, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.652607 · Cited by 12
Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion
Shah, A., Box, A. H., Brenn, T., & Flaman, A. N. (2024) · Journal of Cutaneous Pathology · doi:10.1111/cup.14602 · Cited by 11
“16 Functionally, BRD4-NUT proteins are retained within the nucleus as a result of bromodomain – chromatin interactions.”
BackgroundMusa, R. E., Lester, K. L., Quickstad, G., Vardabasso, S., Shumate, T. V., Salcido, R. T., Ge, K., & Shpargel, K. B. (2024) · Development · doi:10.1242/dev.202110 · Cited by 12
Hurd, C. A., Bush, J. T., Powell, A. J., & Walport, L. J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202406414 · Cited by 11
Discovering Protein Interactions and Characterizing Protein Function Using HaloTag Technology
Daniels, D. L., Méndez, J., Benink, H. A., Niles, A. L., Murphy, N., Ford, M., Jones, R. C., Amunugama, R., Allen, D., & Urh, M. (2014) · Journal of Visualized Experiments · doi:10.3791/51553-v · Cited by 11
The potential underlying mechanism of the leukemia caused by MLL‐fusion and potential treatments
Liu, H., Lee, S., Zhang, Q., Chen, Z., & Zhang, G. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23204 · Cited by 11
“cognize acetylated histone tails, BRD4 contains an extra terminal domain which recognizes JMJD6.(99,100) Incidentally, we found that JMJD6 nonspecifically binds to single stranded RNA with high affinity (~40 nM).”
BackgroundNishiyama, A., Dey, A., Tamura, T., Ko, M. S. H., & Ozato, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034719 · Cited by 11
“Although the underlying mechanism is not fully clear, a direct or indirect interaction between DC and full length Brd4 may explain the dominant negative effect [43,44,45].”
BackgroundMarkouli, M., Strepkos, D., & Piperi, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113657 · Cited by 10
“…with super-enhancers that are related to pivotal MM genes, including cyclin D2 ( CCDN2 ), PR/SET domain 1 ( PRDM1 ), X-Box binding protein 1 ( XBP1 ), or myeloid cell leukemia sequence 1 (BCL2-Related) ( MCL1 ) [74], and recruits lysine methyltransferases and arginine demethylases (Figure 2) [92].”
BackgroundRetractedHan, H., Lv, F., Liu, Z., Chen, T., Xue, T., Liang, W., & Liu, M. (2023) · Molecular Plant Pathology · doi:10.1111/mpp.13331 · Cited by 10
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
Hashimoto, M., Masuda, T., Nakano, Y., Tobo, T., Saito, H., Koike, K., Takahashi, J., Abe, T., Ando, Y., Ozato, Y., et al. (2024) · Cancer Science · doi:10.1111/cas.16129 · Cited by 10
A meiotic driver hijacks an epigenetic reader to disrupt mitosis in noncarrier offspring
Yu, H., Zhang, J., Yang, M.-Y., Zhang, F.-Y., Ren, J.-Y., Lyu, X.-H., Ding, Y., Suo, F., Shao, G.-C., Li, J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408347121 · Cited by 10
Sun, Z., Zhang, H., Chen, Z., Xie, Y., Jiang, H., Chen, L., Ding, H., Zhang, Y., Jiang, H., Zheng, M., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.012 · Cited by 10
Liu, H., Wei, P., Zhang, Q., Chen, Z., Liu, J., & Zhang, G. (2022) · Biomolecules · doi:10.3390/biom12030347 · Cited by 11
“histone tails, BRD4 contains an extra terminal domain (ET) that recognizes JMJD6 [151,152].”
BackgroundSETD6 Regulates E2-Dependent Human Papillomavirus Transcription
Jose, L., Androphy, E. J., & DeSmet, M. L. (2022) · Journal of Virology · doi:10.1128/jvi.01295-22 · Cited by 10
“Brd4 recruits proteins like the NSD3 methyltransferase to modify histones and stimulate transcription (35).”
BackgroundHistone Signatures Predict Therapeutic Efficacy in Breast Cancer
Mollah, S. A., & Subramaniam, S. (2020) · IEEE Open Journal of Engineering in Medicine and Biology · doi:10.1109/ojemb.2020.2967105 · Cited by 10
“showed binding of BRD4/NSD3 consistent with a previous study [22], where reduced H3K36 methylation was a result of the depletion of BRD4 or NSD3.”
BackgroundLotke, R., Schneeweiß, U., Pietrek, M., Günther, T., Grundhoff, A. T., Weidner-Glunde, M., & Schulz, T. F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.591778 · Cited by 10
Lalu, A. C., Lubaba, F., Gopalakrishnan, A. P., Mahin, A., Subair, S., Shivamurthy, P. B., Rajeev, A. C., & Raju, R. (2025) · DNA and Cell Biology · doi:10.1089/dna.2025.0088 · Cited by 9
“In diseases such as cervical cancer, hyperactive BRD4 phosphorylation supports uncontrolled growth (Rahman et al., 2011), and disrupting phosphorylation through inhibitors can halt proliferation, highlighting its regulatory signi fi cance (Rahman et al., 2011; Hu et al., 2022).”
The BRD4-nucleosome interaction is enhanced modestly and non-selectively by histone acetylation
Lambrechts, L., Reid, X. J., Kambanis, L., Luong, C., Kobakhidze, E., Daners, A., Zhong, Y., Patel, K., Franck, C., Sani, H. M., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1406 · Cited by 9
“It is notable that the ET domain of BRD4 can interact with subunits from several such complexes [ 62 , 63 ].”
Qiang, Y., Fan, J., Xie, C., Yan, L., Song, X., Zhang, N., Lin, Y., Xiong, J., Zhang, W., Liu, Y., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2888 · Cited by 9
Zhang, S., & Roeder, R. G. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01384-6 · Cited by 9
“BET proteins also possess an ET domain that binds multiple transcriptional regulators 5,6 acting as ‘effectors’ to regulate transcription.”
Gargano, D., Segatto, M., & Bartolomeo, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065665 · Cited by 12
When are the BET factors the most sensitive to bromodomain inhibitors?
Khochbin, S. (2013) · Transcription · doi:10.4161/trns.23191 · Cited by 9
“These observations are also in line with the fact that, at least in the case of Brd4, Brd3 and Brd2, important regulatory functions of the corresponding proteins have been shown to be independent of the bromodomains.(15) Additionally, and in support of these conclusions, it has been reported that the expression of som…”
ResultDrugging transcription in heart failure
Padmanabhan, A., & Haldar, S. M. (2019) · The Journal of Physiology · doi:10.1113/jp276745 · Cited by 9
“The ET domain is an approximately 80 amino acid conserved region whose function is poorly understood, but is likely involved in scaffolding transcription effector proteins (Rahman et al. 2011).”
BackgroundMurali, M., & Saloura, V. (2022) · Genes · doi:10.3390/genes13112013 · Cited by 8
Pellaers, E., Bhat, A., Christ, F., & Debyser, Z. (2022) · Viruses · doi:10.3390/v15010032 · Cited by 8
“The BDs contain hydrophobic amino acids, which interact with acetylated lysine residues on histones (Figure 1A; red domains), while the ET domain binds the MLV IN [139,140] (Figure 1A; purple domain).”
BackgroundThe P53–P21–RB1 pathway promotes BRD4 degradation in liver cancer through USP1
Li, N., Zhang, E., Li, Z., Lv, S., Zhao, X., Qian, K., Zou, Q., Li, W., Wang, Y., Guo, H., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105707 · Cited by 8
“Interestingly, WDR48 was also identi fi ed in the immunoprecipitate of BRD4 in the same proteomic study (28), adding to the con fi dence in USP1 identi fi cation.”
Transcription Pause and Escape in Neurodevelopmental Disorders
Eigenhuis, K. N., Somsen, H. B., & van den Berg, D. L. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.846272 · Cited by 9
Metadata
- Authors
- Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M.
- Affiliations
- Harvard University (US)
- Corresponding author
- Howley, Peter M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-07-01
- Volume
- 31
- Issue
- 13
- Pages
- 2641-2652
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3133372
- OpenAlex
- W2167732604
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 25 · 2025: 14 · 2024: 41 · 2023: 39 · 2022: 35 · 2021: 55 · 2020: 37 · 2019: 41 · 2018: 39 · 2017: 42 · 2016: 40 · 2015: 30 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG011085, R01AG011085)
- National Cancer Institute (T32CA009361, R01CA116720)
- National Institute of General Medical Sciences (GM054137, R01GM054137, R01GM070565)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- BRD4, NSD3, JMJD6, ATAD5, CHD4, H3K36 methylation, chromatin recruitment, BET proteins, BRD2, BRD3, protein-protein interaction, histone modifications
- MeSH terms
- Bromodomain Containing Proteins, Amino Acid Sequence, Cell Line, Chromosomal Proteins, Non-Histone, Humans, Molecular Sequence Data, Nuclear Proteins, Histone-Lysine N-Methyltransferase, Transcription Factors, Transcriptional Activation, Protein Structure, Tertiary, Cell Cycle Proteins, Tumor Suppressor Proteins, Positive Transcriptional Elongation Factor B, Jumonji Domain-Containing Histone Demethylases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.